FDA Inspection 1307736 - Paul W. Wallace, MD - March 17, 2026

FDA Inspection 1307736 for Paul W. Wallace, MD on March 17, 2026. Classification: N/A.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1307736 for Paul W. Wallace, MD on March 17, 2026. Classification: N/A.

Violation Codes

21 CFR 312.60

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Paul W. Wallace, MD

Inspection Date

March 17, 2026

Product Type

Human Drugs

Office

Los Angeles District Office

ID: f6ed70f6-0bc5-4521-9c11-8fcd6786192e

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox